Donald C Vinh is an expert in Infectiology at McGill University Health Centre (Canada). As of October 2026, ScienceLeadR ranks Donald C Vinh in the top 1% of experts worldwide for Coronavirus Infections, COVID-19 and Pneumonia. Donald C Vinh has authored 232 publications, the most recent in 2026, and is an investigator in 4 clinical trials. SLR score: 821 (community average: 125). How the SLR is computed.

LeadR Profile

821 ScienceLeadR Reputation 821
Network Map

Infectiology

Subspecialties: Immunology - Hematology - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Short Biography

Dr. Vinh is Infectious Disease physician, Medical Microbiologist and Section head (ID-Hematology-Oncology/Transplant) at the McGill University Health Centre. He did his medical school at McGill University, followed by Internal Medicine residency there, Infectious Disease fellowship at the University of Manitoba, Medical Microbiology training back at McGill, and then a three-and-a-half year post-doctoral research fellowship at the NIH (in the lab of Dr. Steve Holland), working on inborn errors of immunity to fungi and MonoMAC due to GATA2 deficiency. He returned to McGill at the end of 2010. He is a provincially-funded Senior Clinician-scientist. His lab is at the forefront of CARD9 deficiency and deciphering the mechanisms underlying its associated fungal infections; has discovered a combined immunodeficiency syndrome due to recessive mutations in ICOS-Ligand; and has contributed to deciphering susceptibility to viral disease, including discovery of RIG-I deficiency in Kaposi sarcoma. His translational research program continues to decipher how molecular defects of human immunity contribute to infections that are recurrent, recalcitrant, and/or unusually severe in patients. He is an elected fellow of the Association of Medical Microbiology and Infectious diseases (AMMI) Canada; inaugural fellow of the Clinical Immunology Society; elected fellow of the Infectious Disease Society of America; and elected member of the Henry Kunkel Society.

Organizations

Career arc: 2005 - 2026

Source: PubMed

McGill University Health Centre

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 232

Citations

Citations: 19 095 1st author: 35 Last author: 37 Unique author: 12


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Effects of β-hydroxy-β-methylbutyrate (HMB) and/or 2-hydroxybenzylamine (2-HOBA) on markers of healthspan in older adults (H2AGE trial): study protocol of a randomised controlled trial at the Canadian Translational Geroscience Network.
PMID 42864138 — geroscience
BMJ Open20260
Affinity-matured B cell responses neutralizing type-I interferons underlie severe viral infections.
PMID 42097138 — cells, antibodies, cell biology, interferon type i, b-lymphocytes, infections, virus diseases, autoimmunity
Cell Top journal20260
Three Doses and Six Months Later: Real-World SARS-CoV-2 Specific Humoral and Cell-Mediated Immunity in Children With Inborn Errors of Immunity.
PMID 42034835 — cells, sars-cov-2, immunity, cellular, immunity, severe acute respiratory syndrome-related coronavirus, child
J Clin Immunol20260
Underrated, Unvaccinated, Untreated: A Multinational Registry Analysis of Human Metapneumovirus in Hematological Malignancy, Insights From EPICOVIDEHA/EPIRESEHA Registry.
PMID 41852556 — registries, mortality, opportunistic infections, vaccines, hematologic neoplasms, neoplasms, influenza, human, metapneumovirus, viruses, therapeutics, intensive care units, infections
Open Forum Infect Dis20260
Human retinoic acid-inducible gene I deficiency is associated with susceptibility to classic Kaposi sarcoma.
PMID 41780571 — cells, genes, sarcoma, kaposi, sarcoma, viruses, immunity, immunity, innate, immunosuppression therapy, virus latency, antiviral agents, infections, dna viruses, tretinoin
J Allergy Clin Immunol20260

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 2
Phase 3 1
Phase 4 1

By status:

Active not recruiting 1
Completed 1
Terminated 1
Unknown 1

By type:

Interventional 2
Observational 2

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 3

Main Topics

Cohort/Consortium Investigators 6

LeadR Networks

Main global connection map